AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
SARASOTA, FLA. - Epileptics who are on anticonvulsant therapy during pregnancy have a 5% risk of fetal malformations, which is double the risk seen in the general population, Dr. Jennifer R. Niebyl said at a perinatal symposium sponsored by Symposia Medicus.
The most common birth defects in this group are cleft lip / cleft palate and congenital heart defects. In addition, 1% of epileptic women treated with valproic acid during pregnancy will have a baby with neural tube defects, and 5%-10% of fetuses exposed to hydantoin will have fetal hydantoin syndrome, which includes microcephaly growth deficiency developmental delays and mental retardation, dysmorphic craniofacial features, and hypoplasia of nails and distal phalanges.
Despite this, it is well recognized that the benefits of anticonvulsant therapy in pregnancy outweigh the risks as long as the therapy is truly necessary said Dr. Niebyl, professor and head of the department of obstetrics and gynecology at the University of Iowa in Iowa City.
For this reason, she strongly recommends that women with epilepsy who are ...
Source: HighBeam Research, Reevaluate Necessity of Anticonvulsants in Pregnancy.